Indices extended intraday recovery with the Sensex and the Nifty regaining the positive zone in mid-morning trade. At 11:28 IST, the barometer index, the S&P BSE Sensex, was up 15.40 points or 0.04% at 35,253.08. The Nifty 50 index was up 12.75 points or 0.12% at 10,611.15. Pharma shares gained.
Key benchmark indices edged lower in early trade on negative Asian stocks. Stocks cut losses in morning trade.
The S&P BSE Mid-Cap index was up 0.78%. The S&P BSE Small-Cap index was up 0.52%. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was positive. On the BSE, 1215 shares rose and 952 shares fell. A total of 125 shares were unchanged.
Overseas, Asian stocks were trading lower on lingering worries over US-China trade relations. On the data front, China's consumer inflation remained at the second-highest level so far this year, buoyed by an acceleration in non-food prices, official data showed Friday. The consumer price index rose 2.5% in October from a year earlier, unchanged from the growth in September, the National Bureau of Statistics said.
US stocks closed mostly lower yesterday, 8 November 2018 as the Federal Reserve kept interest rates unchanged in an unanimous decision and signaled that it would continue to tighten monetary policy at a gradual pace. As expected, the Fed kept its benchmark target for rates unchanged in a 2% to 2.25% range.
Back home, pharma shares gained. Cadila Healthcare (up 1.71%), Glenmark Pharmaceuticals (up 2%), Lupin (up 0.29%), Sun Pharmaceutical Industries (up 3.04%), Alkem Laboratories (up 0.52%), GlaxoSmithKline Pharmaceuticals (up 0.36%), Aurobindo Pharma (up 1.78%) and Wockhardt (up 2.52%) gained. Cipla (down 1.1%) and Dr Reddy's Laboratories (down 1.21%) fell.
Linde India jumped 16.53% to Rs 565.80 after the company's founder, the BOC Group, sought proposal to delist Linde India's equity shares from the stock exchanges. The BOC Group holds 6.39 crore equity shares, representing 75% of the paid up share capital of Linde India. The announcement was made during trading hours today, 9 November 2018.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
